APP and neurodegenerative disease: The IRP-IRE signaling pathway is implicated to participate in the regulation of APP and α-syn translation, and the use of small-molecule IRE chemical inhibitors to reduce APP and α-syn levels and attenuate protein aggregation may have therapeutic implications for neurodegenerative diseases in humans.